See the DrugPatentWatch profile for Veozah
What is Veozah (fezolinetant) used for?
Veozah (fezolinetant) is a prescription medicine used to treat moderate to severe hot flashes associated with menopause. It works by blocking the neurokinin 3 (NK3) receptor, which helps reduce the hot-flash signal.[1]
How does Veozah work?
Fezolinetant is an NK3 receptor antagonist. By blocking NK3 signaling, it reduces hot-flash frequency and severity in people with menopausal hot flashes.[1]
How is Veozah taken?
The provided information does not include dosing or administration details for Veozah. [1]
What side effects are associated with Veozah?
The provided information does not list Veozah’s side effects. [1]
How does Veozah compare with other hot-flash treatments?
The provided information does not include a comparison between Veozah and other therapies for menopausal hot flashes. [1]
Is Veozah protected by patents or exclusivity, and when do they end?
DrugPatentWatch.com tracks intellectual-property status and patent links for drugs. For Veozah (fezolinetant), you can check the latest patent/exclusivity details at the DrugPatentWatch.com page.[1]
Where can I find Veozah patent and market data?
DrugPatentWatch.com provides patent and related market-intelligence links for Veozah. Start here: [1]
Sources
[1] https://www.drugpatentwatch.com/